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Fibromyalgia (FM) is a chronic pain condition that is second only to 
osteoarthritis. Fibromyalgia greatly impacts the quality of life with its many symptoms 
requiring a multidisciplinary approach to treatment. The recommendation is that patients 
with fibromyalgia are treated in primary care as are other chronic diagnoses such as 
hypertension and diabetes with referrals to other disciplines as needed. However, some 
primary care providers may not recognize fibromyalgia as a valid diagnosis, have 
received inadequate formal training in fibromyalgia, and may have limited awareness of 
diagnostic criteria.  
According to the research, there are as many as 3 out of 4 people with 
fibromyalgia that go undiagnosed in any primary care practice. Providers in primary care 
are usually the first to evaluate patients, therefore, providers in primary care need to 
recognize fibromyalgia symptoms, start initial treatment, and refer for further 
consultation if required. Fibromyalgia (FM) symptoms can be debilitating, prolonged, 
and negatively affect the patient's lives, environment, and family and friends. Decreases 
in physical ability, intellectual activity, emotional condition are some of the 
consequences of FM. Professional careers, personal relationships, and mental health may 
require, requiring several strategic interventions by several disciplines in healthcare 
settings. Making the need for the use of a screening tool that includes the diagnostic 
criteria essential. Fibromyalgia occurs frequently in the general adult population 
worldwide, no treatment that cures, and limited knowledge of the cause has produced 
patient dissatisfaction with the time it takes to diagnose, formulate a treatment plan, and 
as a result, has led to the development of this DNP project. Given fibromyalgia 
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symptomatology, absenteeism from work with a decreased quality of life, and the 
inability it often produces, it is essential that providers, especially in primary care, be 
knowledgeable regarding the diagnostic criteria for FM using a screening tool. Using the 
American College of Rheumatology (ACR) screening tool will assist in early diagnosis 
and treatment. The screening tool consists of symptom severity (SS) and widespread pain 
index (WPI), with no curative diagnostic screening which aids in early diagnosis and 
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CHAPTER I - INTRODUCTION 
Fibromyalgia (FM) is a chronic, complex disease characterized by diffuse chronic 
mild, moderate, and severe widespread pain (SWP) and chronic fatigue syndrome (CFS), 
often reported as the worst symptom associated with fibromyalgia (Baron et al., 2014). 
Other distressing symptoms include sleep disturbances, gastrointestinal symptoms, 
memory problems, headaches, tingling, stiffness, numbness, decreased libido, bowel, 
bladder difficulties, anxiety, and depression, an overwhelming length of time. Many 
debilitating symptoms make it very difficult to diagnose and treat (Baron et al., 2014). 
The American College of Rheumatology (2021) estimates that about 2% of the world's 
population meets the 2010 modified diagnostic criteria for fibromyalgia syndrome.  
Those patients diagnosed with FM reported that they are never free from 
symptoms. Wierwille (2011) noticed that the diagnostic goal is to promote treatment 
early and improve life quality by reducing symptoms. Working with FM patients can 
become disheartening for providers because of the difficulty in diagnosing and finding an 
effective and proven treatment that works for their patients. When a person has FM 
symptoms, many patients have been evaluated by several providers, including specialists 
and a long list of diagnostic tests, without a definitive diagnosis (Arnold et al., 2011). In 
most instances, the patient first reports to their provider in primary care without a 
definitive diagnosis. Therefore, it is essential to educate providers in primary care about 





The most common chronic pain condition is seen in primary care, and the least 
diagnosed is FM. There are at least twenty undiagnosed FM patients in the average 
primary care clinic (Wolfe et al., 2010). The American College Rheumatology's (ACR) 
(2021) recommended tool for diagnosing FM, using the ACR diagnostic criteria 
screening tools, is the widespread pain index (WPI) and severity of symptoms (SS). This 
DNP project aimed to educate providers in primary care on the diagnostic criteria tool 
needed for a definitive diagnosis. 
Significance 
FM is a controversial condition where this population has seen numerous 
providers when a definitive diagnosis has been provided. Some of these providers are 
rheumatologists, general practitioners, pain specialists, and mental healthcare specialists. 
The FM population may complain of SWP, CFS, depression, intestinal symptoms, 
headaches, and many other complaints. We now know a complex presentation of 
symptoms as FM remains challenging to providers due to the multifaceted list of 
symptoms. 
The most common chronic pain condition is seen in primary care is FM and is the 
least diagnosed. There are at least twenty undiagnosed FM patients in a primary care 
clinic (Wolfe et al., 2010). The American College Rheumatology's (ACR) (2021) 
recommended tool for diagnosing FM, using the ACR diagnostic criteria screening tools, 
is the widespread pain index (WPI) and SS. This DNP project aimed to educate providers 
in primary care on the diagnostic criteria tool needed for a definitive diagnosis. This DNP 
project aimed to educate providers in primary care on the diagnostic criteria tool needed 
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for a definitive diagnosis. For years, disagreements took place over the legitimacy and the 
need for a diagnostic label. What would be the classification, what division of medicine 
would take ownership, and what treatment protocols and options would benefit the FM 
population are just a few of the questions posed by the medical community (Häuser & 
Fitzcharles, 2018). 
Chen and McKenzie-Brown’s (2015), research estimated that about 2% of the 
population meets the 2010 modified diagnostic criteria of the American College of 
Rheumatology (2021) for fibromyalgia syndrome in the developed world's population. 
FM occurrence is higher in women, although it also occurs in children and men. All 
ethnic groups are affected and may affect other family members between the ages of 20 
to 50. Incidences of FM rise with age; by age 80, about 8% of the adult population in the 
world meet the American College of Rheumatology classification of fibromyalgia. 
Despite these research findings, many providers doubt FM diagnosis and point to 
depression, pain, or insomnia as the main issues of the FM population (Chen & 
McKenzie-Brown, 2015). 
Problem Statement, Clinical Question, and PICOT 
According to a survey conducted by primary care providers, as many as two-
thirds of these providers have problems distinguishing FM from other disorders and were 
not well trained in FM diagnosis (Arnold et al., 2011, p. 8). Providers in primary care 
manage many complex chronic diseases, and FM diagnosis and treatment should occur in 
primary care. The FM diagnosis often does not occur due to providers' lack of knowledge 
regarding FM and there are not any clear guidelines for management. Every FM patient 
has to be treated as an individual.  
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There is a significant knowledge gap of providers in primary care settings that 
causes delays in diagnoses and treatment for those with the complex array of symptoms 
that accompany FM (Arnold et al., 2016). According to Arnold et al. (2016), research 
providers who suspect FM will refer to a rheumatologist or other providers to diagnose 
and provide treatments. The knowledge gap is related to uncertainty, unavailability, or 
unawareness of the ACR diagnostic criteria screening tool. 
Database searches were performed to find evidence-based research on the PICOT 
question: PICO (T) Question: does educating providers on the availability and use of the 
ACR preliminary diagnostic criteria screening tool in primary care improve the provider's 
confidence in their ability to diagnose fibromyalgia in primary care?   
Available Knowledge 
Management of complex chronic diseases by providers in primary care is routine, 
and patient referrals as needed for a patient-centered approach to providing care. These 
same criteria should apply to FM as a chronic disease where education is necessary, is 
incorporated into treatment goals, and continued follow-up applies. In managing the FM 
population, the provider must consider more than one treatment goal; treatment is long-
term and requires a strategic approach for each person’s array of symptoms. 
The provider must treat all symptoms to effectively manage the FM population 
(Arnold et al., 2012). Many providers often avoid FM patients due to the complexity of 
the illness and later refer to specialists as quickly as possible. The time needed to educate 
patients regarding FM is not cost-effective. The routine follow-up visits are usually 
lengthy and may cause diminished reimbursements, increase overhead, and bureaucratic 
demands. Providers performing a complete medical history, physical examination, using 
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the ACR diagnostic criteria tool, and blood work to rule out other diseases can quickly 
diagnose FM in most patients (Fitzcharles et al., 2018). 
According to Fitzcharles et al. (2018), FM is a chronic illness with various 
symptoms. Hence, the FM population needs long-term, continuous care and knows that 
treatment goals will change over time based on the ongoing evaluation. Almost all care 
providers in primary care are qualified to manage FM patients, and FM patients should 
only refer to a rheumatologist, psychiatrist, psychologist, or other specialists if needed 
(Fitzcharles et al., 2018).   
Instead, the new criteria require the examiner to fully assess the patient's concerns 
and perform a thorough physical examination. It is impossible to know the extent of 
unrefreshed sleep, fatigue, cognitive issues, and degree of pain without a detailed 
interview and the use of a diagnostic screening tool as part of the protocol to diagnose 
FM. The 2010 ACR diagnostic criteria screening tool obligates the provider to focus 
extensively on the subjective complaints to give a definitive diagnosis of FM (Wolfe, 
2010) (see Appendix A). 
Galvez-Sánchez and Reyes del Paso (2020) conducted a research study that shows 
88.4% sensitivity and specificity of 81.1% using 1990 ACR criteria to screen for FM will 
differentiate FM from other rheumatic conditions. With rheumatoid arthritis (RA) and 
osteoarthritis (OA), the ability to distinguish from FM with the sensitivity of 96.6% and 
the specificity of 91.8% Sánchez and Reyes del Paso (2020). In 2010, the ACR 
diagnostic criteria for diagnosing FM cut-off value of WPI increased from greater than or 
equal to 14 from 7 and SS from greater than or equal to 5 to 7 with 100% diagnostic 
accuracy for FM Galvez-Sánchez and Reyes del Paso (2020).   
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Furthermore, all patients recruited with the 1990 criteria fulfilled the 2010 
criteria, suggesting a good diagnostic agreement between both sets of criteria (Galvez-
Sánchez & Reyes del Paso, 2020). When the 2010 ACR criteria cut-off values were 
maximized up to WPI ≥ 14 and SS ≥ 7, specificity and diagnostic accuracy of 100% were 
achieved (Galvez-Sánchez & Reyes del Paso, 2020). Studies using logistic regression 
analysis showed that the ability to discriminate between FM and RA patients was higher 
for the WPI (95.9% overall accuracy) than for the SS (87.1% overall accuracy) (Galvez-
Sánchez & Reyes del Paso, 2020). 
Galvez-Sánchez and Reyes del Paso (2020) conducted a research study that shows 
88.4% sensitivity and specificity of 81.1% using 1990 ACR criteria to screen for FM will 
differentiate FM from other rheumatic conditions. With rheumatoid arthritis (RA) and 
osteoarthritis (OA), the ability to distinguish from FM with the sensitivity of 96.6% and 
the specificity of 91.8% Sánchez and Reyes del Paso (2020). In 2010, the ACR 
diagnostic criteria for diagnosing FM cut-off value of WPI were increased from greater 
than or equal to 14 from 7 and SS from greater than or equal to 5 to 7 with 100% 
diagnostic accuracy for FM Galvez-Sánchez and Reyes del Paso (2020).  
Needs Assessment 
There are gaps in FM research compared to other chronic illnesses, including 
diabetes, rheumatoid arthritis, and asthma; thus, this has caused some providers to be far 
behind in their understanding and therapeutic approaches to FM (Clauw et al., 2017). The 
ACR published the first diagnostic criteria for classification for FM in 1990, requiring a 
definitive diagnosis of FM to have at least eighteen of the tender points on the body and 
widespread pain for at least three months (Wolfe, 2010). This 1990 ACR assessment 
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evaluates the tenderness points on the body according to defined thresholds. With this 
assessment, there must be at least eleven tender points of eighteen points and widespread 
pain for at least three months (Wolfe, 2010). The provider could assess the tender points 
by applying a standardized pressure of 4 kg to turn a thumbnail white to the tender points, 
and three months of these symptoms (Wolfe, 2010).   
Carol Burckhardt and Sharon Clark at Oregon Health and Science University in 
Portland, Oregon, published the Fibromyalgia Impact Questionnaire (FIQ) in 1991. The 
FIQ attempted to teach the spectrum of fibromyalgia problems and therapy responses 
because fibromyalgia’s clinical features were just being discovered. Since that time, it has 
been extensively used to index disease activity and therapeutic efficacy (Bennett et al., 
2009).  
However, after two decades, the ACR proposed new criteria in 2010, which 
removed the Revised Fibromyalgia Impact Questionnaire (RFIQ) tender points. The 
RFIQ is an updated version of the FIQ with excellent psychometric properties, and can be 
completed in less than 2 minutes, and is easy to score. The RFIQ has scoring 
characteristics comparable to the original FIQ, making it possible to compare past FIQ 
results with future RFIQ results (Bennett et al., 2009).   
Research has shown that healthcare providers may overlook rheumatic disorders 
that have inaccurately been diagnosed as FM. In 2010, the ACR introduced new 
diagnostic criteria. The new diagnostic criteria require the provider to fully examine the 
patient’s problem list to obtain a clearer path to a definitive diagnosis. This DNP project 
aims to educate providers on the diagnostic criteria tool's availability and how to use the 
tool. (Arnold et al., 2011).  
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This DNP project endeavors to provide data indicating that using the screening 
tool will improve making definitive diagnoses. The decisions that providers make about 
diagnosis, treatment, prescribing, referrals, and tests are based on the healthcare 
provider's knowledge, their confidence in that knowledge, and their experiences using the 
knowledge. FM is a complex condition in which the population presents with multiple 
symptoms, where adequate education and diagnostic screening tools must be used with 
chronic pain patients to give a definitive diagnosis early (Arnold et al., 2010).   
Wolfe's (2010) study reveals that the new diagnostic criteria for FM eliminate the 
tender point examination because, of difficulty to perform for some providers, causing 
distractions and delays in diagnosing. With the new ACR diagnostic criteria, eleven 
tender-point exams were removed and replaced with the WPI, proving more information 
regarding the extent and threshold of pain. Eliminating the tender points exam does not 
suggest that physical examination is no longer required for patients, nor does the removal 
of the eleven tender points lighten the provider's role in the diagnosing of FM. Instead, 
the new criteria require the examiner to fully assess the patient's concerns and perform a 
thorough physical examination. It is impossible to know the extent of unrefreshed sleep, 
fatigue, cognitive issues, and degree of pain without a detailed interview, and the use of a 
diagnostic screening tool as part of the protocol to diagnose FM. The 2010 ACR 
diagnostic criteria screening tool obligates the provider to focus extensively on the 




Synthesis of Evidence 
Fibromyalgia FM has a negative and substantial impact on the lives of patients 
and families. FM can affect the quality of life and dramatically changes the person's 
ability to independently perform vital personal needs and affect family, friends, and 
employer's relationships (Arnold et al., 2008). FM may be so debilitating that the person 
may become incapacitated and unable to work to the point of requiring assistance with 
activities of daily living. Fibromyalgia is the most common chronic pain condition, 
second only to osteoarthritis, and worldwide, FM affects all ethnic and medical 
communities in the same measure. According to the National Fibromyalgia Association 
(NFA, 2015), FM cost is very costly for individuals and society due to its debilitating 
nature and multiple symptoms. Hence, the need for early diagnosis and treatment is 
essential for all stakeholders. The initial plan has to be to identify the diagnosis of FM, 
start treatment timely and rule out or confirm other comorbidities (Arnold et al., 2008). 
A research study conducted by Arnold et al. (2011) found that despite some 
improvement in understanding the process of FM and its pathologic as many as 3 out of 4 
people with FM-like symptoms remain undiagnosed and undertreated. From the 
beginning of symptoms to the time of diagnosis may take an average of 5 years with 
potential suboptimal medical care and delay in treatment. Hence, a vital part of successful 
management is establishing FM's diagnosis early and starting treatment (Arnold et al. 
2011). Providers in primary care see more patients with undiagnosed FM than are any 
other providers (Arnold et al., 2011). When FM is diagnosed, both providers and patients 
can see a clear path to overcome a significant hurdle to manage the disorder effectively 
together (Arnold et al., 2011). 
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Arnold et al. (2011) state the evaluation to diagnose FM may take more time than 
allowed for a patient routine visit, but providers in primary care should not let this fact be 
a barrier in their practices. If FM is suspected or confirmed, treatment should begin 
immediately, and the evaluation has to continue for possible coexisting disorders (Arnold 
et al., 2011). In this same research study, Arnold et al. (2011) found that improving 
recognition and diagnosing FM is essential. FM can affect the quality of life and become 
a burden on the economy due to remaining underdiagnosed as well as undertreated even 
with increased awareness and interest in the disorder (Arnold et al., 2011). 
Migraine headaches and back pain are chronic pain illnesses similar to FM, and as 
such, it is appropriate for providers in primary care to diagnose and treat FM (Arnold et 
al., 2011). A research study on the ACR diagnostic criteria screening tool states that the 
tool will assist with an early diagnosis, treatment and increasing the provider's 
confidence. Using the ACR diagnostic criteria to diagnose or rule out FM will allow the 
provider in primary care to explore and make other diagnoses of other diseases with 
similar symptoms (Arnold et al., 2011). 
In practice, primary care providers are often the first health professionals the FM 
population patients consult regarding their many symptoms causing such poor quality of 
life (Baron et al., 2014). The ACR recommends that their diagnostic criteria screening 
tool be used in addition to the patients' symptoms, comorbidities, medical history, and the 
results of laboratory tests in primary care to establish a diagnosis. Because incorrect 
diagnosis remains very frequent, patients are likely to undergo multiple consultations and 
referrals before receiving a positive diagnosis and adequate care management. Delayed or 
misdiagnosis, along with the condition itself, has a significant impact on a patient's 
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emotional state and quality of life, society, and health care costs (Baron et al., 2014). 
ACR diagnostic criteria are widely available and are very sensitive to confirming FM, but 
the criteria are rarely used to establish FM diagnosis.   
Hence, using the ACR diagnostic criteria screening tool, the primary care 
provider will translate patients' complaints and experiences into clues to help the provider 
manage the patient in primary care. Baron et al. (2014), created a scoring method using a 
series of repeating steps for the process based on statistical and clinical considerations 
with the American College of Rheumatology called FibroDetect. The study included FM 
patients and non-FM patients. The FibroDetect tool included fourteen questions assessing 
patients' pain and fatigue, personal history and attitudes, symptoms, and impact on lives.  
A FibroDetect tool was found to have a 90% sensitivity and specificity of 67% (Baron et 
al., 2014). In contrast, the ACR diagnostic screening tools remain the best choice because 
it has sensitivity and specificity for the criteria to 90.2% and 89.5% (Baron et al., 2014).  
Arnold, Gebke, and Choy's (2016) systematic review revealed that for most FM 
diagnoses to occur in primary care, providers must have the training and access to 
screening tools and assist with recognizing FM, providing the provider with the 
confidence needed to identify and diagnose FM. According to Arnold et al. 2016, 
providers in primary care received little training in basic pain assessment or management 
of chronic pain. If the appropriate training has been provided to primary care providers, it 
is too brief to be helpful or remembered. Additional ongoing training is most likely 
needed for primary care providers and can be obtained by some form of regularly 
scheduled continuing education on assessing pain and FM (Arnold et al., 2016).  
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Delay in diagnosing FM might be the lack of knowledge of diagnostic criteria 
screening or the lack of time allotted for patient visits in primary care is not enough for 
the FM patient to discuss all of their symptoms. The many symptoms associated with FM 
have to be discussed and evaluated (Arnold et al., 2016). As patients might on the 
visitation present with one or two symptoms commonly associated with FM, such as lack 
of interest in things that once caused pleasure, chronic fatigue syndrome, a provider must 
be sure to inquire about pain as a part of the assessment even if the patient does not report 
the pain (Arnold et al., 2016). The ACR diagnostic criteria screening tool could improve 
diagnostic accuracy, reduce delays in initiating treatment and provide education for the 
FM patients. Patient education is essential in aiding in the understanding, acceptance, and 
learning to self-manage FM (Arnold et al., 2016). According to Arnold et al. (2016), the 
primary care provider's role is unique with the FM patients, and forming a therapeutic 
relationship between the provider and the patient is necessary to provide needed support 
for the FM patient. The WPI and SS, part of the ACR preliminary diagnostic screening 
tool, should be completed at every visit. This will help providers have the subjective 
information from the patient, Arnold et al. (2016). When the WPI and SS part of the form 
is completed by the FM patient and reviewed with the patient at each visit by the primary 
care provider, communication between patients and providers will improve, causing a 
trustful therapeutic relationship (Arnold et al., 2016).  
According to Arnold et al. (2016), the primary care provider is unique and must 
form a therapeutic relationship that provides support. The use of the ACR diagnostic 
screening tool at every visit, which consists of scoring of WPI and SS, will also help 
patients’ education. When the form is completed and reviewed with the patient at each 
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visit, it improves communication between the patient and provider. Poor communication 
may cause frustration in the patient leading to over-reliance on pharmacological 
interventions with little benefit.   
The ACR diagnostic criteria will provide a guideline for early diagnosing and 
early treatment for all patients who present with chronic pain. The ACR will also help 
relieve the provider's insecurities in diagnosing and treating (Arnold et al., 2016). FM is a 
clinical diagnosis that a primary care provider should make based on the disorder's 
clinical characteristics (Arnold et al., 2016). Prompt symptom recognition leads earlier, 
leading to an earlier starting of treatment using the ACR diagnostic criteria screening tool 
for all patients who present with chronic pain complaints (Arnold et al., 2016). 
Bernstein’s 2015 article states that in the diagnosis of FM, there is no disease to 
cure. FM, a complex illness that speaks to overwhelming pervasive symptoms, and often 
symptoms are more significant than are experienced by patients with organ system 
diseases such as heart failure and some cancers. The provider's role is not to question or 
denigrate the patient's motives but to understand the context in which they suffer and 
comprehend the disease's nature. Since there is no disease to cure, there must be aid and 
support in times of hardship and distress to address FM's symptoms.  
Historically, the concepts about fibromyalgia were incorrect. It was believed that 
FM was a disease of yes or no. This response is untrue because individuals in this 
population have different levels or volume control settings for sensory processing in their 
brains. The higher this volume or level is, the more pain response that comes from the 
brain. This response causes FM patients to rate their pain as mild, moderate, severe, or 
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unbearable FM patients and can change daily in severity. Making FM an indistinct 
disease of fluctuating symptoms (Fitzcharles et al., 2018).  
There has been a huge surge in the research studies conducted on FM for the past 
thirty years. This research surge might be in part to the stakeholders' increase in 
knowledge and interest, including patients with FM, their families, organizations labeled 
self-help, the pharmaceutical industry, researchers, and providers (Häuser & Fitzcharles, 
2018). Before a condition can be recognized as a disease, the World Health Organization 
(WHO) must officially recognize it. In 1992, the WHO recognized FM as a disease. In 
1994, in the 10th revision of the International Classification of Diseases (ICD-10), FM 
was listed as a musculoskeletal system disease and connective tissue with ICD 10 code of 
M79.7 (Häuser & Fitzcharles, 2018).  
Despite the legitimacy of FM by WHO, there are healthcare providers that do not 
believe that FM exists. Many are diagnosed with FM when other providers for other 
conditions are being told that FM does not exist. This issue is, in part, believed to be 
because there are not any objective findings to diagnose FM. FM must be diagnosed by 
subjective data collected from those presenting to see a provider with their many 
symptoms (Häuser & Fitzcharles, 2018).  
According to (WHO), FM is a real disease, a legitimate disease in the pain field, 
but the literature still shows doubter. FM is the poster child for a common type of pain 
originating from the brain and central nervous system rather than ongoing tissue damage 
inflammation. Why is it so difficult for providers to believe that FM pain originates from 
the brain while we readily accept phantom limb pain and headaches? Many chronic pain 
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conditions such as fibromyalgia, irritable bowel, TMJ disorder, interstitial cystitis are 
believed to originate from the brain, not from peripheral tissues.   
Just as many other chronic pain syndromes are diagnosed and treated by providers 
in primary care, so should FM.  Some of the discomforts present in diagnosing and 
treating FM are because the problem deviates from providers' normal training on tissue 
and organs. FM individuals feel any sensory experiences as more painful and unpleasant 
than would occur peripherally in those without FM because the problem is that the 
volume control for sensory processing is higher in the brain (Bernstein 2015). 
Search 
A systematic, electronically strategic search was conducted to capture the most 
relevant research for diagnosing FM. An electronic search of databases that included 
Medline search, EBSCOhost, Cochrane Reviews, and Google Scholar to access peer-
reviewed articles. The purpose of the searches was to find peer-reviewed articles related 
to diagnosing FM in primary care. The terms related to the PICOT questions were 
searched: primary care, fibromyalgia, chronic pain, evidence-based practice, economic 
burden, screening tools, protocols, and diagnostic criteria for adults 18 years and above. 
Because a primary care setting is usually the first appointment that the FM population 
makes and presents to the provider with multiple symptoms, including CPS, and steadfast 
health concerns they have had to endure for many years. It is essential to diagnosing FM 
early by determining whether providers in primary care are aware of the diagnostic 
criteria tool. If the diagnostic criteria tool is used by providers in the primary care setting 
to screen for FM in patients with complaints of chronic pain, to ensure that early 
diagnosis and treatment will occur. 
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Focused Topics and Evidence-Based Findings 
Management of FM in primary care may be challenging for providers even 
though much evidence-based research about the underlying pathophysiologic 
mechanisms involved in FM is available. (Fitzcharles et al., 2018). When providers find 
it challenging to identify and diagnose FM, this prevents them from communicating this 
information to patients. Despite this, there is a growing recognition of FM by patients 
with many symptoms, so more people seek medical help and make frequent visits to 
providers in primary care (Fitzcharles et al., 2018). Thus, FM is a problem commonly 
seen in primary care that decreases the quality of life and becomes an economic burden. 
With time and resources limited in primary care clinics, those presenting with multiple 
symptoms accompanying FM may be perceived as complex, especially since 
standardized treatment protocols are unavailable (Fitzcharles et al., 2018).  
Arnold et al. (2012) report that FM is a chronic disease that significantly affects 
several parts of a patient's life, including engaging in work and everyday activities, which 
may lead to some FM patients being perceived as challenging to treat by their providers. 
However, it is important to assess all areas that are impacted by symptoms of FM and to 
work collaboratively with the patient in a patient-centered approach during follow-up to 
prioritize goals for treatments (Arnold et al., 2012). Pain and symptoms of FM may be 
assessed using the ACR WPI and SS scale. These scales will evaluate and validate pain, 
cognitive and physical abilities, and other health-related quality of life assessments 
(Arnold et al., 2012). Using the ACR assessment tools to assist with goal setting when a 
patient is diagnosed with FM will give the provider a baseline of health status. Progress, 
decline, or improvements can be monitored at each visit using this tool (Arnold et al., 
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2012). Other tools are available that providers may use to assess the impact of FM on 
patients'. The Fibromyalgia Impact Questionnaire (FIQ) and the revised version (RFIQ). 
The RFIQ considers three areas: function, effect, symptoms; it takes less than 2 minutes 
to complete. In 2010, a new version of the diagnostic criteria based on the WPI and SS 
scales was introduced by the ACR (Galvez-Sánchez & Reyes del Paso, 2020). 
The ACR criteria introduced the SS scale, the development of scales based on the 
2010 criteria, which help with diagnosis and evaluation of the severity of the disease, and 
measures the extent of fatigue, unrefreshed sleep, cognitive problems, and diversity of 
symptoms. (Galvez-Sánchez & Reyes del Paso, 2020). The SS score correlates with the 
widespread pain index (WPI) at 0.733, and the tender point counts at 0.680 and is used as 
part of FM criteria. (Galvez-Sánchez & Reyes del Paso, 2020). These scales fully capture 
the actual content of fibromyalgia for the provider. (Galvez-Sánchez & Reyes del Paso, 
2020). The modifications have improved the sensitivity and specificity for the criteria to 
90.2% and 89.5%, respectively. The scale captures the differences in the severity of 
symptoms in all patients (Galvez-Sánchez & Reyes del Paso, 2020).  
The ACR criteria introduced the SS scale based on the 2010 criteria, which helps 
diagnose, evaluate the severity of the disease, and measure the extent of fatigue, 
unrefreshed sleep, cognitive problems, and diversity of symptoms. (Galvez-Sánchez & 
Reyes del Paso, 2020). The SS score correlates with the widespread pain index (WPI) at 
0.733, and the tender point counts at 0.680 and is used as part of FM criteria. (Galvez-
Sánchez & Reyes del Paso, 2020).These scales fully capture the actual content of 
Fibromyalgia for the provider. (Galvez-Sánchez & Reyes del Paso, 2020). The 
modifications have improved the sensitivity and specificity for the criteria to 90.2% and 
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89.5%, respectively. The scale captures the differences in the severity of symptoms in all 
patients (Galvez-Sánchez & Reyes del Paso, 2020).  
The ACR criteria introduced the SS scale, the scale which is based on the 2010 
criteria, which helps to diagnose and evaluate the severity of disease, and the extent of 
fatigue, unrefreshed sleep, cognitive problems, and diversity of symptoms are measured 
(Galvez-Sánchez & Reyes del Paso, 2020). The SS score correlates with the widespread 
pain index (WPI) at 0.733, and the tender point counts at 0.680 and is used as part of FM 
criteria (Galvez-Sánchez & Reyes del Paso, 2020). These scales fully capture the actual 
content of Fibromyalgia for the provider. (Galvez-Sánchez & Reyes del Paso, 2020). 
Modifications to the criteria' forms, sensitivity, and specificity, have improved to 
90.2% and 89.5%, respectively (Galvez-Sánchez & Reyes del Paso, 2020). These scales 
capture the differences in the severity of symptoms in all patients (Galvez-Sánchez & 
Reyes del Paso, 2020). According to Wolfe (2010), using the 2010 ACR classification 
criteria was performed well in primary care, specialty clinics and provided patients 
homogeneity for clinical trials. However, providers in primary care are slow to embrace 
the criteria. This lack of criteria use may be due to the lack of education on the ACR's 
diagnostic criteria changes.  
The project's goal was that the providers would evaluate and diagnose FM early in 
primary care clinics. The new practice strategy will improve the delay in initial 
diagnosing, starting treatment, and earlier referrals if needed. The benefit of using the 
diagnostic tool from the ACR is to decrease the time necessary to diagnose FM, improve 
provider knowledge of diagnosing FM, and encourage the starting of treatment early by 
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providers in primary care (Wolfe 2010). Early diagnosis will lessen the economic burden 
and the stress of the FM population.  
In, Mexico, 6 European countries, and South Korea, a questionnaire survey of 
1622 physicians were conducted by Perrot et al. (2012) that included primary care 
physicians, rheumatologists, neurologists, psychiatrists, and pain specialists. Results were 
that greater than 80% of the providers had seen a patient with FM in the past year. Perrot 
et al.'s (2012) result revealed that only 32% did not know about FM. More than 53% 
reported difficulty when it comes to diagnosing FM. Only 32% lacked knowledge of the 
American College of Rheumatology classification criteria. FM is challenging to diagnose 
and manage (Perrot et al., 2012). Many providers are not confident in developing a 
treatment plan and managing FM patients long-term (Perrot et al., 2012).  
Rationale, Theoretical Framework, Models, Concepts/Theories 
The Common-Sense Model of Self-Regulation (CSM) is a widely used conceptual 
framework that explains the processes by which patients with chronic diseases become 
aware of a health threat. The CSM helps an individual navigate effective responses to the 
threat, then formulate perceptions of the danger and potential treatment actions. Thereby, 
they can create action plans for addressing the risk and integrate continuous feedback to 
evaluate the action plan and threat progression (Leventhal et al., 2016).  
The CSM model captures the layperson's understanding of their bodily changes or 
symptoms and focuses on five domains of symptoms: 1) identification of symptoms as an 
illness, 2) causes of the symptoms, 3) the timeline of how long the disease will last or the 
seriousness of the condition, 4) consequences of the disease and its symptoms, and 5) 
curability/controllability or what they will be able to do about the illness or symptoms 
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(Leventhal et al., 2016). The CSM may be used in chronic medical conditions when there 
was no apparent pathophysiological explanation, high uncertainty, lack of a productive 
cure, and has a high incidence of emotional problems. Providers' decisions about 
diagnosis, referrals, tests and prescribing are influenced by the providers' perceptions and 
vary between providers. Thus, while there is ambiguity over the diagnostic criteria for 
FMS, variations in clinicians' beliefs will determine the care patients receive (Pastor et 
al., 2012). 
Regardless of practice size, age of practice, or specialty of practice, change plays 
an influential role in any healthcare practice. Kurt Lewin developed his change method 
theory in the 1940s, and his ideas of evolution and motivation in the workplace are very 
relevant in this century. Lewin's theory will work well in most practices because change 
is an ongoing process and involves action planning, fact-gathering, and communicating 
throughout each of his three stages of change, known as unfreeze, movement, and 
refreeze (Hussain et al., 2018).  
The process ensures more precise expectations and shared understandings for 
those involved and affected by the desired change (Hussain et al., 2018). In Lewin's 
theory, unfreezing disrupts the current processes that are in place and introduce the 
expected or desired change (Hussain et al., 2018). The second stage, called a movement, 
or change, requires people to adopt the new process or change by promoting active 
involvement and open communication. The third stage, refreeze, reinforces the unique 
patterns of behaviors to sustain the transition by providing ongoing support, follow-up, 
and assistance to individuals using a new process (Hussain et al., 2018). 
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Lewin’s Change Theory Applied 
This DNP project’s unfreezing stage involved educating working providers in a 
primary care setting to learn the importance of using the ACR preliminary diagnostic 
screening tool for those who present with chronic pain. The providers were given a pre-
educational screening questionnaire. The stakeholders are the providers in the primary 
care clinic who also own the clinic, so their involvement was crucial to the process of 
unfreezing (Porter-O’Grady & Mallach, 2015). 
The change phase of this DNP project was the providers’ education on using the 
diagnostic criteria screening tool. A virtual education was provided by a voice-over 
PowerPoint explaining the tool’s use and how the tool is scored. The providers were 
given a chance to ask questions and review their answers to the questionnaire (Porter-
O’Grady & Mallach, 2015). 
Finally, in the unfreezing phase, the provider was willing to incorporate the use of 
the ACR diagnostic criteria screening tool for all who present with chronic pain 
complaints. A post-educational questionnaire was given to the providers and reviewed 
(Porter-O’Grady & Mallach, 2015). 
Specific Aims 
According to Wolfe (2010), using the 2010 ACR classification criteria was found 
to have performed well in primary care, specialty clinics and provided patients 
homogeneity for clinical trials. However, providers in primary care are slow to embrace 
the criteria. This lack of criteria use may be due to the lack of education on the ACR's 
diagnostic criteria changes. 
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The project's goal was that the providers would evaluate and diagnose FM early in 
primary care clinics.  The new practice strategy will improve the delay in initial 
diagnosing, starting treatment, and earlier referrals if needed. The benefit of using the 
diagnostic tool from the ACR is to decrease the time necessary to diagnose FM, improve 
provider knowledge of diagnosing FM, and encourage the starting of treatment early by 
providers in primary care (Wolfe 2010). Early diagnosis will lessen the economic burden 
and the stress of the FM population. 
Early diagnosis can improve anxiety, reduce depression, and prevent ER visits 
due to pain and other symptoms that may occur when diagnosing is delayed. This DNP 
project's measurable objective is the early diagnosis and treatment of patients with FM by 
providers in primary care will be improved to at least 90% (Wolfe, 2010). FM should be 
considered in patients who present in primary care with mood changes, chronic pain, 
unrefreshed sleep, and fatigue, even though the symptoms can represent a diagnostic 
challenge.  Many of these patients may meet the fibromyalgia criteria (Fitzcharles et al., 
2018). However, due to the lack of education of the provider of the diagnostic criteria 
that can be used by the provider, it can be potentially frustrating in diagnosing and 
management in primary care. Recent studies have improved our understanding of the 
diagnostic criteria by using the ACR diagnostic criteria tool. Education of providers will 
lead to early diagnosis, improve the provider's confidence, and lead to significant and 
appropriate management of FM in primary care (Fitzcharles et al., 2018). 
Doctor of Nursing Practice Essentials 
The Doctor of Nursing Practice (DNP) Essentials outlines foundational 
competencies fundamental to advanced nursing practice roles. DNP Essentials include 
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scientific underpinnings for practice organizational and system's leadership for quality 
improvement and systems thinking; clinical scholarship and analytical methods for 
evidence-based practice; information systems technology and patient care technology for 
improvement and development of transformation of health care; health care policy for 
advocacy in healthcare; interprofessional collaboration for improving patient and 
population outcomes; clinical prevention and population health for improving the 
nation’s health and advance the nursing practice (AACN, 2006). All eight elements are 
essential, but Essentials I, II, III, and VIII were mainly addressed by this DNP project.  
DNP Essential I: Scientific Underpinnings for Practice: Essential I is met using 
the diagnostic criteria for fibromyalgia from the ACR. The common-sense model guides 
the project as an educational tool. Lewin's theory will work well in most practices 
because change is an ongoing process and involves action planning, fact-gathering, and 
communicating throughout each of his three stages of change, known as unfreeze, 
movement, and refreeze   
DNP Essential II: Organizational and Systems Leadership for Quality 
Improvement and Systems: The essential was met after assessing the site’s needs. It led 
to providing evidence-based training to the providers to improve patients’ quality care by 
educating them on diagnostic criteria to diagnose fibromyalgia recommended by the 
ACR. Therefore, the enhancement of providers' education on the need for diagnostic 
criteria will lead to an early diagnosis and treatment of fibromyalgia.  
DNP Essential III: Clinical Scholarship and Analytical Methods for Evidence-
based Practice: Essential III was met by promoting the ACR recommendation as an 
educational tool as an intervention for the providers to use to improve patient outcomes. 
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It was also reached by analyzing various literature to decide the right approach for this 
project. The providers were given a copy of the diagnostic criteria after a pre-educational 
survey/questionnaire of the provider’s confidence in diagnosing FM.  
DNP Essential VIII:  Advanced Nursing Practice: Essential VIII was met by 
moving forward with this project to educate the providers on the diagnostic criteria 
according to the ACR to diagnose fibromyalgia. Educating providers on the diagnostic 
criteria tool will improve the screening and diagnosing of fibromyalgia by an evidence-
based tool.  
Summary 
The ACR has questionnaires designed to assess and validate pain, and it can also 
evaluate health-related quality of life such as physical, cognitive, and emotional in FM 
patients (Arnold et al., 2012). Using these questionnaires as part of each visit assessment 
can give a baseline health status and updated health status and aid in setting goals that the 
patient and the provider may monitor progress. The patient fills in these questionnaires 
when visiting a doctor (Arnold et al., 2012).  
These Questionnaires designed to assist with diagnosing fibromyalgia include the 
Fibromyalgia Impact Questionnaire (FIQ) and the revised version (FIQR) (Arnold et al., 
2012). The RFIQ assesses (functional abilities, symptoms, and the symptoms' impact on 
the patient) using 21 check-box questions completed in less than 2 minutes (Arnold et al., 
2012).   
The new ACR version of the preliminary diagnostic criteria screening tool in 
2010 was based entirely on two scales:  the Symptom Severity (SS) Scale and the 
Widespread Pain Index (WPI) Galvez-Sanchez & Reyes del Paso, 2020). These two 
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scales were added to the preliminary diagnostic criteria screening tool by the ACR and 
may be used at each visit as part of the patient's assessment. Using these two scales will 
let the patient and the provider know their current health status (Galvez-Sanchez & Reyes 
del Paso, 2020). Educating providers in a primary care setting on the availability of these 





CHAPTER II - METHODOLOGY 
In introducing this intervention to the primary care clinic, the researcher must 
communicate educational intentions while informing the providers of the need to use the 
diagnostic tool for diagnosing FM. Patients presenting to primary care clinics with 
complaints of widespread generalized chronic pain patients should be screened for FM. If 
screening of these patients occurs this will help eliminate or decrease the length of time 
the patient spends without a diagnosis. The FM patient experiences many symptoms so 
much so it is hard to articulate all the symptoms to the provider. The ACR diagnostic 
screening tool addresses widespread pain, the severity of symptoms, and the assessment 
of the many somatic symptoms. Using this tool will aid the FM patient to have the ability 
to see symptoms in print and answer accordingly.  
Population and Sample 
The population of focus for this project was all patients 18 years and above that 
presented to the primary care clinic with complaints of widespread chronic pain (pain 
more than three months). This project was completed in a rural health clinic in central 
Mississippi. The ACR preliminary diagnostic criteria screening tool for FM will be used 
as a part of the routine assessment of chronic widespread pain patients. There are two 
providers in the clinic and they see between 40 and 50 patients a day. 
Intervention 
The availability and the use of the ACR diagnostic screening tool were the focus 
of the synthesis of evidence.  The interventions focused on improving recognition, 
diagnosing of FM by the introduction of the ACR screening tool. This intervention will 
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decrease the lack of knowledge of the ACR screening tool and provide education on the 
tool.  
Part 1. Retrospective chart review to determine the number of adults 18 years and 
older experiencing widespread chronic pain for longer than three months. This chart 
review was from January 1, 2020, to January 1, 2021, with a complaint of chronic pain 
ICD 10 code G89.4 was conducted by the DNP student. The DNP student reviewed the 
charts to see if the patients were diagnosed with FM and if a screening tool was used.   
Part 2. The participants of the intervention were the primary caregivers working at 
a rural health clinic in central Mississippi. 
1. A pre-intervention questionnaire was sent to the providers via Qualtrics to be 
completed. The consent form was included and had to be agreed to before the 
pre-questionnaire could be completed. 
2. A voice-over educational PowerPoint covering the history, diagnosing, and a 
copy of the ACR preliminary diagnostic criteria for FM was sent to the 
providers for review after the pre-intervention questionnaire was sent.  
3. A post-intervention questionnaire was sent to providers via Qualtrics for 
completion. 
4. The providers were able to ask questions regarding intervention via Zoom. 
Measures 
A questionnaire, both pre- and post-education, was utilized to evaluate the level of 
understanding of the diagnostic criteria for FM after the educational intervention was 
completed. The providers were allowed to ask questions regarding the educational 
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intervention via Zoom before the completion of the post-questionnaire. A copy of the pre-
and post-education questionnaires is located in Appendix B. 
Analysis 
The DNP student was the only individual collecting data from the charts via 
computer documentation software. The important data elements were identified, 
recorded, and then organized into the form created by this DNP student.  The information 
gathered from the pre-education and post-education questionnaires were used to 
determine the effectiveness of the educational intervention.  Quantitative statistics were 
utilized. 
The question for evaluation for this DNP project was among patients 18 years and 
above who present to primary care clinic with complaints of widespread chronic pain 
lasting longer than three months, does educate providers on the availability and use of the 
ACR diagnostic screening criteria tool, compared to not educating the providers in 
primary care on the use and availability of the ACR diagnostic criteria tool, improve the 
provider's ability to diagnose fibromyalgia in primary care?   
Qualitative research methods look deeper into the problem to uncover trends in 
thoughts. The interview method with providers was used before the project started, a pre-
test was sent to the providers to be completed in Qualtrics, and the education of the 
providers took place by a voice-over PowerPoint presentation. After the voice-over 
PowerPoint presentation, each provider was sent a post-test in Qualtrics to complete.  
Ethical Considerations 
The DNP project involved de-identified patient charts for review by this DNP 
student.  An Institutional Review Board (IRB) application was submitted and approved 
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by The University of Southern Mississippi (Protocol # IRB-19-591). The following 
COVID-19 precautions were taken during the implementation of this DNP project: This 
DNP student was the only researcher in a private area with access to the computer, 6 feet 
social distancing, facial coverings, disinfecting surfaces before and after use, hand 
washing, or hand sanitizer use. No additional contact was made. The project aims to 
facilitate the early detection, diagnosis, and treatment of FM in those evaluated in 
primary care using the ACR diagnostic screening tool. This new practice strategy will 
improve the delay in initial diagnosing, starting treatment, and earlier referrals if needed. 
The benefit of using the diagnostic tool from the ACR is to decrease the time needed to 
diagnose FM, improve provider knowledge of diagnosing FM, and encourage the starting 
of treatment early by providers in primary care. Early diagnosis will lessen the economic 
burden and the stress of the FM population. 
Data consists of all de-identified data that will be maintained on the researcher's 
password-protected personal computer. The de-identified electronic data will be deleted 
six months after all graduation requirements have been met (June 2022). Physical data 
will be kept in a locked file cabinet at this researcher's home office and will be shredded 
six months after graduation requirements have been met on June 30, 2022.  
Fibromyalgia symptoms often mimic many other conditions. Determine the cause 
of symptoms is the key to receiving a proper diagnosis for FM or other diagnoses. Some 
providers are unaware of the change to eliminate the digital palpation of tender points as 
part of FM's diagnostic criteria (Galvez-Sanchez & Reyes del Paso, 2020). FM is a severe 
burden to persons, society and is a health problem that can lead to overdiagnosis, 
overtreatment, or inadequate treatment of FM patients. Acceptance of FM by health 
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professionals and the general public must be achieved, which will assist with proper 
treatments, and decrease the burden on persons and society (Galvez-Sanchez & Reyes del 
Paso, 2020). The project's focus outcome seeks to help with the knowledge of the change 
by educating providers on using the latest ACR diagnostic criteria. Each provider can 
inform their colleagues and their community of the new diagnostic criteria. Providers in 
primary care can make an early diagnosis of Fibromyalgia, start treatment or rule out 
Fibromyalgia, and search for other possible diagnoses.  
A retrospective chart review could be done by another researcher three months 
after this project to evaluate the use of the ACR diagnostic screening form and if 
fibromyalgia is being diagnosed, in addition, are the patients being treated in the clinic or 
referred? 
Project Timeline 
1. The researcher did a retrospective chart review of 18-year-olds previously seen 
in the clinic complaining of chronic pain with ICD 10 code G89.4. The data were 
collected from February 1, 2020, to February 1, 2021. The providers were sent a link to 
complete a pre-questionnaire in Qualtrics where the consent was completed before the 
questionnaire could be started. 
 2. The project was conducted over four weeks at a primary care clinic. All 
patients presenting to the clinic with a complaint of chronic pain longer than three months 
were assessed for fibromyalgia using the ACR diagnostic criteria.  The scores of each 
patient were calculated, and the provider reviewed the assessment with the patients. 
3.  The following week the voice-over PowerPoint was delivered to the clinic on a 
jump drive for the providers to watch and send back to the researcher with questions 
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added which were addressed in the executive summary that will be sent to the providers 
after the project has been completed. 
4.  One week after the educational intervention was received back by the 
researcher from the providers, they were sent a link to complete the post-questionnaire 
questions in Qualtrics. 
Summary 
This DNP project was focused on educating providers in primary care clinics on 
the availability of the ACR Preliminary Diagnostic Criteria for FM. Learning of the ACR 
Diagnostic criteria will aid providers to assess, diagnose, and treat and/or refer as needed. 
The ACR can become a part of the patient’s permanent chart and can be used as a 
baseline for future visits. The form can measure improvements, remain the same, or be 





CHAPTER III – RESULTS 
The benefits of the providers participating in this DNP project: Fibromyalgia 
affects as many as 4 million U.S. adults, which is 2% of the adult population. The cause 
of fibromyalgia is not known, but it can be effectively treated and managed. This DNP 
project aimed to educate providers in primary care on the availability and use of the 
American College of Rheumatology (ACR) diagnostic criteria screening tool for 
fibromyalgia. Early diagnosis can improve anxiety, reduce depression, and prevent ER 
visits due to pain and other symptoms that may occur when diagnosing is delayed. The 
benefit of using the diagnostic tool from the ACR is to decrease the time needed to 
diagnose FM, improve provider knowledge of diagnosing FM, and encourage the starting 
of treatment early by providers in primary care. Early diagnosis will lessen the economic 
burden and the stress of the FM population. The educational voice-over teaching 
regarding the use of the ACR preliminary diagnostic criteria for FM and a copy of the 
form which was given to the providers. This information is evidence-based and provides 
the providers with information and material to make decisions about patient care and 
diagnosing FM. The goal of this DNP project focused on assuring evidence-based 
education in the primary care clinic will be used to diagnose FM. The acknowledgment 
of ethical considerations was maintained throughout the project. Results from the 
retrospective chart review, Pre-Education and Post education Questionnaires, and 
Executive Summary to Facility Administration are discussed in this chapter. 
Results from Retrospective Chart Review 
With the retrospective chart review, there were a total of 100 charts reviewed of 
patients 18 years and above that were diagnoses with chronic pain between February 1, 
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2020, and February 1, 2021. Out of the 100 charts reviewed with chronic pain, 30 were 
diagnosed with fibromyalgia. With the 30 patients diagnosed with fibromyalgia 10 came 
to the clinic already diagnosed with fibromyalgia and 20 were diagnosed by the providers 
in the clinic. For those 20 patients that were diagnosed in the clinic by the providers the 
10- point assessment was used to diagnose fibromyalgia.  
Results from the Pre-Education Questionnaire 
The intervention portion of this DNP project consists of a pre-intervention 
questionnaire being completed by all providers in Qualtrics after electronically signing 
the consent form to participate.  
Table 1  
Pre-Educational Findings 
Questions Responses of Yes Responses of No 
Are you confident in 
diagnosing fibromyalgia? 
6 3 
Have you received adequate 
training in diagnosing 
fibromyalgia? 
4 5 
Do you screen patients for 
fibromyalgia? 
7 2 
Do you screen chronic pain 
patients for fibromyalgia? 
 
5 4 
Do you use a screening tool/s 
to diagnose fibromyalgia? 
4 5 
If you are diagnosed with 
fibromyalgia, do you treat 
the patient? 
5 4 
If you are diagnosed with 




Table 2  
Post-Educational Findings 
Questions Responses of Yes Responses of No 




Will you use the ACR 
diagnosing criteria form on 
all chronic pain patients?  
7 0 
Will you use the ACR 
diagnostic criteria on the 
patient with acute pain that 
also complain of mood 
changes and/or fatigue? 
7 0 
If you diagnose a patient with 
FM will you treat or refer? 
7 0 
Will you use another method 
to diagnose FM?  
0 7 
 
Results from the Post-Education Questionaire 
Based on the findings of the post-education questionnaire, the providers are 
confident in diagnosing, treating, and referring patients as needed. Seven out of 7 
providers confidence in diagnosing fibromyalgia after the educational intervention.  
Summary 
Education of providers in primary care regarding the availability of the ACR 
Preliminary Diagnostic Criteria form will increase the provider's confidence in 
diagnosing FM (Wolfe, 2010). After the educational intervention part of this project, the 
providers' confidence in their ability to diagnose FM increased from 66% to 100 %. The 




CHAPTER IV – DISCUSSION 
Based on the results of the pre-education questionnaire, the providers lack the 
confidence to diagnose FM. Before the educational intervention (66.67%) of the 
providers answered yes to the pre-questionnaire question -are you confident in 
diagnosing FM. After educational intervention (100%) of providers responded yes to post 
questionnaire question-has your confidence in diagnosing FM improved. 
Strengths and Limitations of the Project 
One strength of the project was the provider's willingness to participate in the 
project. If there is a limitation to the project, it would be the number of providers in the 
clinic.  
Key Findings 
In the pre-educational questionnaire, 67% of the providers responded yes when 
asked “are you confident in your ability to diagnose FM.” After the educational 
intervention, the post-questionnaire shows that 100% of all participating providers 
responded yes when asked if their confidence to diagnose FM improved. This DNP 
project does answer the PICO question with yes educating providers in primary care in 
the availability and usage of ACR preliminary diagnostic criteria does improve the 
confidence of the providers to diagnose FM.  
Impact of the DNP Project 
This DNP project shows that educational intervention of the ACR preliminary 
diagnostic criteria does improve providers' confidence in their ability to diagnose 
fibromyalgia. Each provider at the clinic was forthcoming with their lack of knowledge 
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of the ACR preliminary diagnostic criteria and their thankfulness for the introduction of 
this form.  
Summary 
The goal of the DNP project was to improve the confidence of providers in primary care 
clinics' ability to diagnose FM. The project did show that after an educational 
intervention confidence will improve. The use of the ACR form will continue to facilitate 
improved confidence by providers in primary care early diagnosing, treatment, and 
referrals of FM as needed. A retrospective chart review can be done by another DNP 
student 90 days after this DNP project to evaluate the use of the ACR diagnostic 
screening form usage and if fibromyalgia is being diagnosed. Are the patients being 
treated in the clinic or referred? 
Conclusion 
In conclusion, the project evaluated the effectiveness of the educational 
intervention on the providers of this rural health regarding the use of the ACR 
preliminary criteria for diagnosing FM. The project showed that when an educational 
intervention that is focused on certain criteria is presented it does improve the provider’s 
confidence. Another doctoral student can, at a later date, evaluate the overall 
effectiveness of the use of the ACR preliminary diagnostics criteria for FM by doing a 
chart review at a later date. The use of this form will facilitate early diagnosing, treatment 





APPENDIX A – Clinical Diagnostic and Severity Criteria for Fibromyalgia: Widespread 
Pain Index (WPI) and Symptom Severity (SS) Scale 
Criteria  
 
1.  A patient satisfies diagnostic criteria for fibromyalgia if the following 3 conditions are met:  
2. WPI ≥7 and SS scale score ≥5 or WPI 3-6 and SS scale score ≥9  
3. Symptoms have been present at a similar level for at least 3 months.  
4. The patient does not have a disorder that would otherwise explain the pain. 
 
         Ascertainment WPI (0-19)— 
Directions: Note the number of areas in which the patient has had pain during the past week. In 
how many areas has the patient had pain?  
Left and Right Upper back Shoulder girdle  
Left and Right Hip (buttock, trochanter)  




Left and Right Lower leg 
Left and Right upper leg 
Left and Right upper arm 
Left and Right lower arm 
SS scale score (0-12) = Symptom Severity + Extent of Somatic Symptoms Symptom severity— 
Directions: Using the provided scale, indicate the level of severity experienced for each of the 
3 following symptoms:  
Fatigue  
Waking unrefreshed  
Cognitive symptoms  
Scale 0 = no problem 1 = mild: slight, mild, or intermittent problems 2 = moderate: 
considerable problems, often present and/or at a moderate level 3 = severe: pervasive, 
continuous, life-disturbing problems  
The extent of somatic symptoms— 
Directions: Indicate how many somatic symptoms the patient has used the following scale 0 = 
no symptoms 1 = few symptoms 2 = a moderate number of symptoms 3 = many symptoms 
Somatic symptoms that might be considered include muscle pain, irritable bowel  
syndrome, fatigue/tiredness, thinking or remembering problems, muscle weakness, headache, 
pain/cramps in abdomen, numbness/tingling, dizziness, insomnia, depression, constipation, 
pain in the upper abdomen, nausea, nervousness, chest pain, blurred vision, fever, diarrhea, dry 
mouth, itching, wheezing, Raynaud phenomenon, hives/welts, ringing in ears, vomiting, 
heartburn, oral ulcers, loss/change in taste, seizures, dry eyes, shortness of breath, loss of 
appetite, rash, sun sensitivity, hearing difficulties, easy bruising, hair loss, frequent urination, 




APPENDIX B – Pre- and Post-Questionnaires 
Pre-education questionnaire. 
a. Are you confident in diagnosing fibromyalgia? Yes or No 
b. Did you receive adequate training in diagnosing FM? Yes or No 
c. Do you screen patients for fibromyalgia? Yes or No 
d. Do you screen chronic pain patients for fibromyalgia? Yes or No 
e. What screening tool/s do you use to diagnose fibromyalgia? 18 point, WPI, SS, 
or 
other tools/s 
f. If you diagnose a patient with fibromyalgia?  do you treat the patient or do you 
refer the patient? 
 
A pre-recorded video will be sent to the providers via email for review.  
 
 Post-education questionnaire. 
a. Has your confidence in diagnosing FM changed? Yes or No 
b. Will you use the ACR diagnostic criteria on all chronic pain patients? Yes or No 
c. Will you use the ACR diagnostic criteria on the patient with acute pain? 
Yes or No 
d. If you diagnose a patient with FM will you treat or refer? 





APPENDIX C – Doctor of Nursing Practice Essentials 
Essential I: Scientific Underpinnings for 
Practice 
This essential is met using the diagnostic 
criteria for fibromyalgia from the ACR. The 
common-sense model guides the project as 
an educational tool. Lewin's theory will 
work well in most practices because change 
is an ongoing process and involves action 
planning, fact-gathering, and 
communicating throughout each of his three 
stages of change, known as unfreeze, 
movement, and refreeze.  
Essential II: Organizational and Systems 
Leadership for Quality Improvement and 
Systems Thinking 
The essential was met after assessing the 
site’s needs. It led to providing evidence-
based training to the providers to improve 
patients’ quality care by educating them on 
diagnostic criteria to diagnose fibromyalgia 
recommended by the ACR. Therefore, the 
enhancement of providers' education on the 
need for diagnostic criteria will lead to an 
early diagnosis and treatment of 
fibromyalgia.  
Essential III: Clinical Scholarship and 
Analytical Methods for Evidence-Based for 
Practice 
This essential was met by promoting the 
ACR recommendation as a screening tool 
for the providers to use to improve patient 
outcomes in primary care clinics. 
Essential IV: Information 
Systems/Technology and Patient Technology 
for the Improvement and Transformation of 
Health Care 
 
This essential was met by suggesting that 
the ACR form become a part of the EHR as 
a screening tool and be used on all patients 
with the complaint of chronic pain 
Essential V: Health Care Policy for Advocacy 
in Health Care 
The project advocated for improving the 
screening process for all patients that 
present to primary care clinics with a 
complaint of chronic pain. 
Essential VI: Interprofessional Collaboration 
for Improving Patient and Population 
This project advocated for improving the 
screening process for chronic pain patients 
and asking the facility to consider adding to 
EHR as an ongoing screening tool. 
 
40 
Essential VII: Clinical Prevention and 
Population Health for Improving the Nation’s 
Health 
The overall purpose of this project is the 
early identification of fibromyalgia.  It is an 
attempt to aid primary care providers in this 
process preventing years of debilitating 
symptoms. 
Essential VIII: Advanced Nursing Practice This essential was met by moving forward 
with this project to educate the providers on 
the diagnostic criteria according to the ACR 
to diagnose fibromyalgia. Educating 
providers on the diagnostic criteria tool will 
improve the screening and diagnosing of 
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